Related Experiment Video

Updated: Apr 23, 2026

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.6K

TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation

Z Mounir1, F Lin1, V G Lin1

  • 1Novartis Institutes for BioMedical Research, Cambridge, MA, USA.

Oncogene
|September 30, 2014
PubMed

Insights

TMPRSS2:ERG gene fusions in prostate cancer (PC) drive tumor cell proliferation and block differentiation. ERG represses neuroendocrine genes, contributing to resistance against anti-androgen therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • TMPRSS2:ERG chromosomal translocations are common in prostate cancer (PC), but their biological consequences are not fully understood.
  • The role of ERG in prostate cancer progression and treatment resistance requires further elucidation.

Purpose of the Study:

  • To investigate the transcriptional effects of TMPRSS2:ERG expression and ERG knockdown in prostate cancer.
  • To identify ERG-regulated genes associated with neuroendocrine differentiation and treatment resistance.

Main Methods:

  • Comparison of transcriptional profiles between a transgenic mouse model and a TMPRSS2:ERG-positive PC cell line.
  • ERG knockdown experiments using cell sorting and proliferation assays.
  • Analysis of neuroendocrine gene expression following AR signaling blockade.

Main Results:

  • ERG represses androgen receptor (AR)-independent neuronal genes, promoting neuroendocrine (NE) differentiation.
  • ERG drives prostate cell proliferation and inhibits differentiation into both NE and luminal cell types.
  • Inhibition of ERG in PC cells increases NE gene expression, leading to AR-targeted therapy resistance.

Conclusions:

  • ERG plays a critical role in driving prostate cancer cell proliferation and preventing differentiation.
  • ERG-mediated repression of NE genes contributes to the development of resistance to anti-androgen therapies.
  • ERG may facilitate tumor repopulation by generating transient, therapy-resistant NE cell populations.

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

46.7K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K